A Randomized, Double-Blind Study to Evaluate the Efficacy of Ethinylestradiol/levonorgestrel + Ethinylestradiol Compared to Placebo For the Management of Menstrually-Related Migraine Headaches.
Latest Information Update: 15 Jul 2012
Price :
$35 *
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary) ; Ethinylestradiol
- Indications Menstrual migraine
- Focus Therapeutic Use
- Sponsors Teva Branded Pharmaceutical Products R&D
- 15 Jul 2012 New trial record
- 23 Jun 2012 Results presented at the 12th Congress of the European Society of Contraception.